4 more Medicare Advantage contracts get 5 stars in revised ratings
Four more Medicare Advantage prescription drug plans have received five-star ratings thanks to CMS’ recalculation. CMS initially unveiled 2026 MA star ratings in October, with 18 MA-PD contracts scoring five stars overall. On July 22, CMS released updated 2026 Medicare Advantage star ratings. The recalculation comes in the fallout of Clover Health’s lawsuit challenging the […] The post 4 more Medicare Advantage contracts get 5 stars in revised ratings appeared first on Becker's Payer Issues |...
View related coverage on the timeline →
Useful signal?
Sign in with GitHub below to react 👍 / 👎, or comment if a category looks wrong — your reactions help curate this feed. How feedback works
Draft Insight Angle
Auto-generated draft — review and edit before any external use.
Clover Health — policy / regulatory changes. Via Becker's Payer Issues.
Analytic angles
- Compare against the current CMS rate/bid-cycle documents.
- Single-source so far — corroborate against a second outlet.
Draft paragraph
[DRAFT — verify before any external use] Becker's Payer Issues reports on policy / regulatory changes involving Clover Health: Four more Medicare Advantage prescription drug plans have received five-star ratings thanks to CMS’ recalculation. CMS initially unveiled 2026 MA star ratings in October, with 18 MA-PD contracts scoring five stars overal…
Note: This is an early signal based on public reporting. Confirm against primary sources before drawing conclusions. Market dynamics may shift as additional information emerges.